Patent: 9,580,739
✉ Email this page to a colleague
Summary for Patent: 9,580,739
Title: | Test for predicting neutralization of asparaginase activity |
Abstract: | Method of in vitro measurement of the presence of factors that are able to neutralize asparaginase activity in a sample of blood, plasma, serum or derived medium that may contain asparaginase neutralizing factors, obtained from a patient, comprising mixing of said sample with asparaginase, incubation of said mixture, then measurement of the residual asparaginase activity in the mixture and determination or quantification of the presence of said neutralizing factors. Method for predicting the efficacy of a treatment with asparaginase. |
Inventor(s): | Godfrin; Yann (Lyons, FR) |
Assignee: | ERYTECH PHARMA (Lyons, FR) |
Application Number: | 14/489,556 |
Patent Claims: | see list of patent claims |
Details for Patent 9,580,739
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2028-11-07 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |